Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Cancer Genes

CRT pioneer fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS

Cancer Research UK and the Cancer Research Technology Pioneer Fund have committed £2.5 million in collaboration with the National Cancer Institute.

9 burning questions about CRISPR genome editing answered

In this post we’ll be exploring the gene editing technology CRISPR by answering some of the most common questions that pop up.

More breast cancer patients than previously thought could benefit from existing targeted treatment

As many as 1 in 5 women with breast cancer could benefit from a drug used to treat ovarian cancer, according to new estimates.

Science Snaps: fixing a cellular ‘antenna’

We find out about how cells can ignore messages that would otherwise control them.

Gene editing stem cells with CRISPR could help understand brain tumours

For the first time, scientists have used the gene-editing tool CRISPR to tweak the DNA of specialised brain stem cells, which could help us understand certain brain...

Researchers reveal how cancer cells cope with genetic chaos

Scientists have uncovered how tumours are able to grow despite significant damage to the structure and number of their chromosomes - the storage units of DNA.

Targeting the cell’s master controller: Myc

Cancer Research UK scientists are finding ways to target the cell's 'master controller', which could have important implications for cancer treatment.

Gene linked to brain defect could point to a new brain tumour drug target

Research into a rare genetic disease could help scientists understand a type of brain tumour.

NCRI Cancer Conference 2016: Day 1 – lung cancer and yeast

We're in Liverpool for the annual National Cancer Research Institute (NCRI) Cancer Conference, sharing updates from the most exciting research on show.

The perfect match: making breast cancer treatment more personal

In the fourth of our series of posts for Stand Up To Cancer, we focus on a clinical trial that's finding faulty genes to improve breast cancer treatment.

Pages